Related content

FOXC2 is a Novel Prognostic Factor in Human Esophageal Squamous Cell Carcinoma

By Nishida Naohiro  

Annals of Surgical Oncology, Vol. 18, Iss. 2, 2011-02 ,pp. : 535-542

Springer Publishing Company

Access to resources Recommend Favorite

STC2: A Predictive Marker for Lymph Node Metastasis in Esophageal Squamous-Cell Carcinoma

By Kita Yoshiaki  

Annals of Surgical Oncology, Vol. 18, Iss. 1, 2011-01 ,pp. : 261-272

Springer Publishing Company

Access to resources Recommend Favorite

IGF2 DMR0 Methylation, Loss of Imprinting, and Patient Prognosis in Esophageal Squamous Cell Carcinoma

By Murata Asuka   Baba Yoshifumi   Watanabe Masayuki   Shigaki Hironobu   Miyake Keisuke   Ishimoto Takatsugu   Iwatsuki Masaaki   Iwagami Shiro   Yoshida Naoya   Oki Eiji   Morita Masaru   Nakao Mitsuyoshi   Baba Hideo  

Annals of Surgical Oncology, Vol. 21, Iss. 4, 2014-04 ,pp. : 1166-1174

Springer Publishing Company

Access to resources Recommend Favorite

Expression of SOX9 and SOX10 in Central Neuroepithelial Tumor: Hamburg, 07.04.2006

By Kordes U.   Hagel C.  

Journal of Neuro-Oncology, Vol. 80, Iss. 2, 2006-11 ,pp. : 151-155

Springer Publishing Company

Access to resources Recommend Favorite

Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma

By Abbaszadegan Mohammad   Raziee Hamid   Ghafarzadegan Kamran   Shakeri Mohammad   Afsharnezhad Sima   Ghavamnasiry Mohammad  

International Journal of Gastrointestinal Cancer, Vol. 36, Iss. 1, 2005-08 ,pp. : 47-53

Humana Press, Inc

Access to resources Recommend Favorite